|
SFXN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.79419999996244E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.08729999999768E-05 |
| Normal-vs-Stage2 |
5.704200E-02 |
| Normal-vs-Stage3 |
2.25029999999515E-05 |
| Normal-vs-Stage4 |
1.395570E-03 |
| Stage1-vs-Stage2 |
3.216200E-01 |
| Stage1-vs-Stage3 |
4.041200E-01 |
| Stage1-vs-Stage4 |
9.064400E-01 |
| Stage2-vs-Stage3 |
1.712990E-01 |
| Stage2-vs-Stage4 |
4.026200E-01 |
| Stage3-vs-Stage4 |
6.451000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.72059999995022E-06 |
| Normal-vs-AfricanAmerican |
2.358300E-02 |
| Normal-vs-Asian |
3.208600E-04 |
| Caucasian-vs-AfricanAmerican |
5.587000E-01 |
| Caucasian-vs-Asian |
8.839400E-01 |
| AfricanAmerican-vs-Asian |
4.980000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.241600E-04 |
| Normal-vs-Female |
3.39009999994477E-06 |
| Male-vs-Female |
6.364400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.790900E-04 |
| Normal-vs-Age(41-60Yrs) |
8.20470000051365E-07 |
| Normal-vs-Age(61-80Yrs) |
5.715500E-03 |
| Normal-vs-Age(81-100Yrs) |
2.452300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.195430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.865000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.859800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.569600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.192200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.416400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.256800E-01 |
| Classical-VS-Follicular |
8.787400E-01 |
| Classical-VS-Other |
4.296800E-01 |
| Classical-VS-Normal |
4.024700E-04 |
| Tall-VS-Follicular |
7.544400E-01 |
| Tall-VS-Other |
6.060000E-01 |
| Tall-VS-Normal |
2.183700E-03 |
| Follicular-VS-Other |
5.900200E-01 |
| Follicular-VS-Normal |
3.022700E-03 |
| Other-VS-Normal |
1.635590E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.70110000000212E-06 |
| Normal-vs-N1 |
1.68460000005144E-06 |
| N0-vs-N1 |
2.191400E-01 |
|
|
